BioWisdom Limited

BioWisdom Limited

June 07, 2006 04:00 ET

BioWisdom Announces Pfizer to Use Sofia KnowledgeScan

CAMBRIDGE, UNITED KINGDOM--(CCNMatthews - June 7, 2006) -

Intelligence Networks to provide an unbiased and systematic view of scientific knowledge

BioWisdom Limited (BioWisdom), a leader in the development and application of Intelligence Networks for the pharmaceutical industry, announced today that Pfizer has signed an agreement relating to the use of Sofia KnowledgeScan™. No financial details of the deal have been disclosed.

Sofia KnowledgeScan™ exploits BioWisdom's powerful Sofia Intelligence Platform to provide unbiased, contextually relevant information to support critical healthcare-related decision-making. The service provides a systematic analysis of available data to tease out intelligence that is relevant to specific commercially sensitive medical issues. Rapid deployment of BioWisdom's Healthcare Intelligence methodology will be provided to compile this information into an Intelligence Network addressing specific scientific and business questions. BioWisdom will also provide industry-trained specialised healthcare analysts to perform the research and present an unbiased expert opinion on the analysed data.

Notes to Editors


BioWisdom creates Intelligence Networks™ using its Sofia suite of tools and proprietary methodology. Intelligence Networks allow unbiased, systematic analysis of problems and are used to support decision-making in all areas of the healthcare industry. The company helps clients to navigate the complex scientific and commercial issues involved in developing successful healthcare products. The BioWisdom team combines extensive experience of the pharmaceutical and biotechnology industries with proven expertise in life science software development.

In April 2006, BioWisdom acquired Lion Bioscience Limited, the bioinformatics business of LION biosciences AG and the SRS suite of data integration products.

For further information please visit

Contact Information